MOREPENLAB — Morepen Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹67.69bn
- IN₹69.24bn
- IN₹18.06bn
Annual cashflow statement for Morepen Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,267 | 558 | 1,354 | 1,551 | 1,199 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -81.8 | -0.257 | 7.28 | 88.1 | -29.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,064 | -1,748 | -962 | -1,608 | -1,236 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -578 | -912 | 734 | 321 | 298 |
| Capital Expenditures | -674 | -460 | -813 | -2,142 | -1,605 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 357 | -5.37 | -19.6 | -1,073 | 371 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -317 | -465 | -833 | -3,215 | -1,234 |
| Financing Cash Flow Items | 98.3 | -2.04 | 13.7 | 331 | -14.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 639 | 1,435 | 52 | 2,999 | 974 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -256 | 58.6 | -47.2 | 104 | 38.1 |